HK1220637A1 - 治療皮膚增厚的方法 - Google Patents

治療皮膚增厚的方法

Info

Publication number
HK1220637A1
HK1220637A1 HK16108819.4A HK16108819A HK1220637A1 HK 1220637 A1 HK1220637 A1 HK 1220637A1 HK 16108819 A HK16108819 A HK 16108819A HK 1220637 A1 HK1220637 A1 HK 1220637A1
Authority
HK
Hong Kong
Prior art keywords
treating skin
skin thickening
thickening
treating
skin
Prior art date
Application number
HK16108819.4A
Other languages
English (en)
Inventor
．布維耶
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of HK1220637A1 publication Critical patent/HK1220637A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK16108819.4A 2013-07-26 2016-07-22 治療皮膚增厚的方法 HK1220637A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361858885P 2013-07-26 2013-07-26
PCT/US2014/048439 WO2015013709A2 (en) 2013-07-26 2014-07-28 Method for treating skin thickening

Publications (1)

Publication Number Publication Date
HK1220637A1 true HK1220637A1 (zh) 2017-05-12

Family

ID=51417558

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16108819.4A HK1220637A1 (zh) 2013-07-26 2016-07-22 治療皮膚增厚的方法

Country Status (11)

Country Link
US (1) US20160166569A1 (zh)
EP (1) EP3024462A2 (zh)
JP (1) JP2016525553A (zh)
KR (1) KR20160055794A (zh)
CN (1) CN105579042A (zh)
AU (1) AU2014292879A1 (zh)
BR (1) BR112016001677A2 (zh)
HK (1) HK1220637A1 (zh)
MX (1) MX2016001104A (zh)
RU (1) RU2016106377A (zh)
WO (1) WO2015013709A2 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150313896A1 (en) * 2013-07-26 2015-11-05 Galderma Research & Development Method for treating cell proliferation disorders
US10493244B2 (en) 2015-10-28 2019-12-03 Becton, Dickinson And Company Extension tubing strain relief
WO2020012415A2 (en) * 2018-07-11 2020-01-16 Clexio Biosciences Ltd. Topical detomidine formulations
FR3119986B1 (fr) * 2021-02-19 2024-02-16 Tarian Pharma Composition émulsion eau dans huile et ses utilisations dans la prévention et/ou le traitement des dommages cutanés causés par les rayonnements
EP4306112A1 (fr) * 2022-07-15 2024-01-17 Tarian Pharma Nouveau regime posologique d'une composition comprenant de la brimonidine pour son utilisation dans la prevention et le traitement des dommages cutanes resultant d'un rayonnement

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7439241B2 (en) * 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
BRPI0511519A (pt) * 2004-05-25 2007-12-26 Sansrosa Pharmaceutical Dev In método para tratar ou prevenir um distúrbio inflamatório da pele e os sintomas associados com ele, composição tópica adequada para tratar ou evitar os sintomas de um distúrbio inflamatório dermatológico, e, embalagem para uma composição tópica
EP2329849B1 (en) * 2009-11-18 2015-04-29 Galderma Research & Development Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder
CN103096894A (zh) * 2010-03-26 2013-05-08 盖尔德马研究及发展公司 用于治疗红斑的包含溴莫尼定的组合物
EP2598129B1 (en) * 2010-06-30 2016-05-11 Galderma Research & Development Use of alpha-adrenergic receptor agonist for preventing or treating skin tumor
EP2731606A1 (en) * 2011-07-14 2014-05-21 Allergan, Inc. Gel compositions of oxymetazoline and methods of use
EP2994120B1 (en) * 2013-05-06 2019-10-09 Allergan, Inc. Alpha adrenergic agonists for the treatment of tissue trauma
EP2994129A4 (en) * 2013-05-07 2017-01-25 Euthymic Bioscience, Inc. Use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane to treat addictive and alcohol-related disorders

Also Published As

Publication number Publication date
WO2015013709A8 (en) 2016-02-18
US20160166569A1 (en) 2016-06-16
EP3024462A2 (en) 2016-06-01
RU2016106377A (ru) 2017-08-31
JP2016525553A (ja) 2016-08-25
KR20160055794A (ko) 2016-05-18
AU2014292879A1 (en) 2016-02-11
MX2016001104A (es) 2016-08-12
BR112016001677A2 (pt) 2017-09-19
WO2015013709A3 (en) 2015-04-09
WO2015013709A2 (en) 2015-01-29
CN105579042A (zh) 2016-05-11

Similar Documents

Publication Publication Date Title
ZA201705673B (en) Methods for treating skin
HK1222530A1 (zh) 用於皮膚處理的微閉合及相關方法
EP2967744A4 (en) SKIN TREATMENT DEVICE
EP2945639A4 (en) METHOD FOR THE TREATMENT OF HEART DISEASES
EP3028722A4 (en) TREATMENT AGENT FOR CARTILAGE DAMAGE AND METHOD FOR THE PRODUCTION THEREOF
ZA201506534B (en) Method of treating hair
PL3084506T3 (pl) Endoskop i sposób jego użycia
HK1215164A1 (zh) 處理方法
AP2015008803A0 (en) Methods for treating psoriasis using an anti-il-23antibody
SG11201510300RA (en) Compositions and methods for treating skin
HK1220637A1 (zh) 治療皮膚增厚的方法
IL240619A0 (en) Method and system for water treatment
EP2941270A4 (en) METHODS FOR TREATING INFLAMMATION
IL241096B (en) Treatment methods
GB201408588D0 (en) Method od depilation
GB201308466D0 (en) Improved process for treatment of minewater
PL3082860T3 (pl) Sposób leczenia ran
HK1224348A1 (zh) 地基的減量化方法
HK1204991A1 (zh) 電燙發處理方法
EP3035925A4 (en) Method for treating neuropathic pain
PT2836176T (pt) Técnica para tratar presbiopia
EP2985265A4 (en) PROCESS FOR TREATING RESIDUAL WATER
SG11201602010VA (en) Heat treatment method
PL3041506T3 (pl) Sposób leczenia
PT2996460T (pt) Método de tratamento de relvado